IBIO Logo

iBio, Inc. (IBIO) 

AMEX
Market Cap
$21.96M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
559 of 774
Rank in Industry
301 of 432

Largest Insider Buys in Sector

IBIO Stock Price History Chart

IBIO Stock Performance

About iBio, Inc.

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the …

Insider Activity of iBio, Inc.

Over the last 12 months, insiders at iBio, Inc. have bought $0 and sold $0 worth of iBio, Inc. stock.

On average, over the past 5 years, insiders at iBio, Inc. have bought $0 and sold $32.83M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,200,000 shares for transaction amount of $1.98M was made by Eastern Capital LTD (10 percent owner) on 2018‑07‑12.

List of Insider Buy and Sell Transactions, iBio, Inc.

2023-11-01SaleSee Remarks
4,881
0.0175%
$0.27$1,296-1.14%
2023-10-03SaleSee Remarks
5,267
0.0187%
$0.30$1,592-1.14%
2023-10-02SaleSee Remarks
4,215
0.0154%
$0.31$1,311-1.14%
2023-08-28SaleSee Remarks
5,011
0.0211%
$0.31$1,529-1.14%
2023-07-27SaleSee Remarks
4,515
0.0337%
$0.51$2,308-1.14%
2023-07-12SaleSee Remarks
47,020
0.3517%
$0.59$27,521-1.14%
2023-06-21SaleSee Remarks
4,184
0.0322%
$0.68$2,849-1.14%
2023-05-22SaleSee Remarks
4,182
0.032%
$0.94$3,910-1.14%
2023-04-24SaleSee Remarks
4,382
0.0338%
$1.20$5,258-1.14%
2023-03-23SaleSee Remarks
5,213
0.0411%
$2.13$11,112-70.24%
2023-02-21SaleSee Remarks
3,976
0.0322%
$1.77$7,038-58.43%
2022-03-10SaleSee Remarks
24,625
0.0112%
$0.35$8,510-31.43%
2021-12-07SaleChief Operating Officer
37,243
0.0164%
$0.68$25,444-59.15%
2020-08-11Sale10 percent owner
15.86M
10.3338%
$2.92$46.33M-43.30%
2020-08-10Sale10 percent owner
7.26M
4.7429%
$3.91$28.43M-57.45%
2020-08-07Sale10 percent owner
1.36M
0.8401%
$3.83$5.19M-58.42%
2020-08-06Sale10 percent owner
2.77M
1.7544%
$4.18$11.57M-61.08%
2020-08-05Sale10 percent owner
900,000
0.5628%
$4.46$4.01M-64.01%
2020-08-04Sale10 percent owner
600,000
0.3697%
$4.39$2.64M-64.01%
2020-06-04SalePresident
28,268
0.0455%
$1.71$48,338+1.18%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.